Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Registrati

Quotazioni in diretta

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares to be sold to cover withholding taxes upon vesting of restricted stock unit award

Date of Notice

10/03/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Stephen Rodin, as Attorney-in-Fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Aadi Bioscience (NASDAQ:AADI)
Storico
Da Feb 2025 a Mar 2025

Clicca qui per i Grafici di Aadi Bioscience

Grafico Azioni Aadi Bioscience (NASDAQ:AADI)
Storico
Da Mar 2024 a Mar 2025

Clicca qui per i Grafici di Aadi Bioscience

Notizie Aadi Bioscience Inc - AADI

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Giovedì 6 Marzo 2025 (3 giorni fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 6 Marzo 2025 (4 giorni fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 5 Marzo 2025 (5 giorni fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 5 Marzo 2025 (5 giorni fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 5 Marzo 2025 (5 giorni fa) • Edgar (US Regulatory)

Form 8-K - Current report
Martedì 4 Marzo 2025 (5 giorni fa) • Edgar (US Regulatory)

Aadi Bioscience Announces Closing of $100 Million PIPE Financing
Martedì 4 Marzo 2025 (5 giorni fa) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 4 Marzo 2025 (6 giorni fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 4 Marzo 2025 (6 giorni fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Martedì 4 Marzo 2025 (6 giorni fa) • Edgar (US Regulatory)

Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders
Lunedì 3 Marzo 2025 (6 giorni fa) • PR Newswire (US)

Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference
Lunedì 24 Febbraio 2025 (2 settimane fa) • PR Newswire (US)

Più Aadi Bioscience Inc Articoli Notizie

Intesa Sanpaolo

Salvatore Ferragamo

Banca Monte Dei Paschi D...

ST Microelectronics

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea